Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001623632-25-001389
Filing Date
2025-10-07
Accepted
2025-10-07 11:11:24
Documents
5

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 11050
2 scynexisamend15exhibit1.htm EX-99 9104
3 scynexisamend15exhibit2.htm EX-99 14333
4 scynexisamend15exhibit3trd.htm EX-99 4195
5 scynexisamend15exhibit3acd.htm EX-99 4155
  Complete submission text file 0001623632-25-001389.txt   44861
Mailing Address 1001 LIBERTY AVENUE PITTSBURGH PA 15222
Business Address 1001 LIBERTY AVENUE PITTSBURGH PA 15222 4122881900
FEDERATED HERMES, INC. (Filed by) CIK: 0001056288 (see all company filings)

EIN.: 251111467 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6282 Investment Advice
(CF Office: 02 Finance)

Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Subject) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88127 | Film No.: 251378722
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)